Immunochemical Analysis of the Antigenic Profile of Human Melanoma Cells with Monoclonal Antibodies

  • Barry S. Wilson
  • Kohzoh Imai
  • Pier-Giorgio Natali
  • Neil E. Kay
  • Renato Cavaliere
  • Michele A. Pellegrino
  • Soldano Ferrone


Tumor immunologists have been investigating the antigenic profile of cancer cells in order to define cellular changes induced by malignant transformation. Characterization of these changes may aid our understanding of the interaction between tumor cells and the host’s immune system, may identify markers to determine the molecular basis of malignant transformation, and may provide unique antigenic determinants to apply immunological approaches for diagnosis and therapy of tumors. We have focused our efforts on melanoma, since this tumor represents a type of human cancer in which the immune response is believed to participate in its pathogenicity and may affect its clinical course. This belief is supported by clinical evidence and by the detection of cellular and humoral immunity to tumor-associated antigens in melanoma patients. Interested readers may refer to recent reviews on these topics (Hellström and Hellström, 1974; Ferrone and Pellegrino, 1978, 1979; Mastrangelo et al., 1979). We have investigated the expression of cytoplasmic and plasma-membrane-bound tumor-associated antigens as well as of histocompatibility antigens on human melanoma cells. The latter antigens have been included in our studies because of their role as informational molecules in the immune response (Benacerraf and McDevitt, 1972) and because of their functional and structural relationships with tumor-associated antigens in certain tumor systems (Callahan et al., 1978; Curry et al., 1979).


Melanoma Cell Melanoma Cell Line Antigenic Determinant Thymic Carcinoma Histocompatibility Antigen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alexander S., Lloyd, K. O., and Strominger, J. L., 1982, Characterization of the HLA-DR antigen of a continuous human melanoma cell line (submitted).Google Scholar
  2. Allison, J. P., Walker, L. E., Russell, W. A., Pellegrino, M. A., Ferrone, S., Reisfeld, R. A., Frelinger, J. A., and Silver, J., 1978, Murine Ia and human DR antigens: Homology of amino terminal sequences, Proc. Natl. Acad. Sci. U.S.A.75: 3953.PubMedCrossRefGoogle Scholar
  3. Avis, P., and Lewis, M. G., 1973, Tumor-associated fetal antigens in human tumors, J. Natl. Cancer Inst.51: 1063.PubMedGoogle Scholar
  4. Benacerraf, B., and McDevitt, H. O., 1972, Histocompatibility-linked immune response genes, Science175: 273.PubMedCrossRefGoogle Scholar
  5. Bonner, W. M., and Laskey, R. A., 1974, A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels, Eur. J. Biochem.46: 83.PubMedCrossRefGoogle Scholar
  6. Boyse, E. A., Stockert, E., and Old, L. J., 1967, Modification of the antigenic structure of the cell membrane by thymus-leukemia (TL) antigens, Proc. Natl. Acad. Sci. U.S.A.58: 954.PubMedCrossRefGoogle Scholar
  7. Brown, J. P., Woodbury, R. G., Hart, C. E., Hellström, I., and Hellström, K. E., 1981, Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues, Proc. Natl. Acad. Sci. U.S.A.78: 539.PubMedCrossRefGoogle Scholar
  8. Callahan, G. N., Pellegrino, M. A., McCabe, R. P., Frugis, L., Allison, J. P., and Ferrone, S., 1978, Histo- compatibility antigens on tumor cells: Spatial and structural relationship with tumor associated antigens, Behring Inst. Mitt.62: 115.Google Scholar
  9. Carey, T. E., Lloyd, K. O., Takahasi, T., Travassos, L. R., and Old, L. J., 1979, AU cell-surface antigen of human malignant melanoma: Solubilization and partial characterization, Proc. Natl. Acad. Sci. U.S.A.76: 2898.PubMedCrossRefGoogle Scholar
  10. Cikes, M., and Friberg, S., 1977, Expression of cell surface antigens on cultured tumor cells, in: Dynamic Aspects of Cell Surface Organization( G. Poste and G. L. Nicolson, eds.), pp. 473–511, Elsevier/NorthHolland, Amsterdam.Google Scholar
  11. Curry, R., Quaranta, V., Wilson, B. S., McCabe, R. P., Natali, P. G., Pellegrino, M. A., and Ferrone, S., 1979, Expression of HLA antigens on cultured human melanoma cells: Lack of association with melanoma associated antigens, in: Current Trends in Tumor Immunology (S. Ferrone, S. Gorini, R. B. Herberman, and R. A. Reisfeld, eds.), pp. 347–366, Garland STPM Press, New York.Google Scholar
  12. Davidsohn, I., 1972, Early immunologic diagnosis and prognosis of carcinoma, Am. J. Clin. Pathol.57: 715.PubMedGoogle Scholar
  13. De Tribolet, N., and Carrel, S., 1980, Human glioma tumor-associated antigens, Cancer Immunol. Immunother.9: 207.CrossRefGoogle Scholar
  14. Dippold, W. G., Lloyd, K. O., Li, L. T. C., Ikeda, H., Oettgen, H. F., and Old, L. J., 1980, Cell surface antigens of human malignant melanoma: Definition of six antigenic systems with mouse monoclonal antibodies, Proc. Natl. Acad. Sci. U.S.A.77: 6114.PubMedCrossRefGoogle Scholar
  15. Eichmann, K., 1980, Conclusion: A simple, conservative model for antigen-specificity and MHC-restriction in lymphocyte communication, Springer Semin. Immunopathol.3: 277.PubMedCrossRefGoogle Scholar
  16. Embleton, M. J., Price, M. R., and Baldwin, R. W., 1980, Demonstration and partial purification of common melanoma-associated antigen(s), Eur. J. Cancer.16: 575.PubMedGoogle Scholar
  17. Fellous, M., Komoun, M., Gresser, I., and Bono, R., 1979, Enhanced expression of HLA antigens and ß2microglobulin on inteferon-treated human lymphoid cells, Eur. J. Immunol.9: 446.PubMedCrossRefGoogle Scholar
  18. Ferrone, S., and Pellegrino, M. A., 1977, Cytotoxic antibodies to cultured melanoma cells in the sera of melanoma patients, J. Natl. Cancer Inst.58: 1201.PubMedGoogle Scholar
  19. Ferrone, S., and Pellegrino, M. A., 1978, Antigens and antibodies in malignant melanoma, in: Handbook of Cancer Immunology, Vol. 3 ( H. Waters, ed.), pp. 291–327, Garland, New York.Google Scholar
  20. Ferrone, S., and Pellegrino, M. A., 1979, Serological detection of human melanoma associated antigens, in: Immunodiagnosis of Cancer( R. B. Herberman and K. R. McIntire, eds.), pp. 588–632, Marcel Dekker, New York.Google Scholar
  21. Ferrone, S., Allison, J. P., and Pellegrino, M. A., 1978, Human DR (Ia-like) antigens: Biological and molecular profile, Contemp. Top. Mol. Immunol. 7:239.Google Scholar
  22. Ferrone, S., Imai, K., McCabe, R. P., Molinaro, G. A., Galloway, D. R., and Reisfeld, R. A., 1980, Production, characterization, and use of xenoantisera to human melanoma-associated antigens, in: Serologic Analysis of Human Cancer Antigens( S. Rosenberg, ed.), p. 445, Academic Press, New York.Google Scholar
  23. Fidler, I. J., Gersten, D. M., and Hart, I. R., 1978, The biology of cancer invasion and metasteses, in: Advances in Cancer Research (G. Klein and S. Weinhouse, eds.), pp. 194–250, Academic Press, New York.Google Scholar
  24. Forni, G., Shevach, E. H., and Green, I., 1975, Mutant lines of guinea pig L2C leukemia. I. Deletion of Ia alloantigens is associated with loss in immunogenicity of tumor-associated transplantation antigens, J. Exp. Med.143: 1067.CrossRefGoogle Scholar
  25. Fujiwara, H., Aoki, H., Tsuchida, T., and Hamaoka, T., 1978, Immunologic characterization of tumor-associated transplantation antigens on mM102 mammary tumor eliciting preferentially helper T cell activity, J. Immunol.121: 1591.PubMedGoogle Scholar
  26. Galloway, D. R., McCabe, R. P., Pellegrino, M. A., Ferrone, S., and Reisfeld, R. A., 1981, Tumor-associated antigens in spent medium of human melanoma cells: Immunochemical characterization with xenoantisera, J. Immunol.126: 62.PubMedGoogle Scholar
  27. Hakomori, S.-I., 1975, Structures and organization of cell surface glycolipids dependency on cell growth and malignant transformation, Biochim. Biophys. Acta414: 55.Google Scholar
  28. Hellström, K. E., and Hellström, I., 1974, Lymphocyte mediated cytotoxicity and blocking serum activity to tumor antigens, Adv. Immunol.18: 209.PubMedCrossRefGoogle Scholar
  29. Herlyn, M., Clark, W. H., Mastrangelo, M. J., Guerry, D., Elder, D. E., La Rossa, D., Hamilton, R., Bondi, E., Tuthill, R., Steplewski, Z., and Koprowski, H., 1980, Specific immunoreactivity of hybridoma secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells, Cancer Res. 40: 3602.PubMedGoogle Scholar
  30. Heron, I., Hokland, M., and Berg, K., 1978, Enhanced expression of ßZ microglobulin and HLA antigens on human lymphoid cells by interferon, Proc. Natl. Acad. Sci. U.S.A.75: 6215.PubMedCrossRefGoogle Scholar
  31. Hersey, R., Murry, E., Werkmeister, J., and McCarthy, W., 1979, Detection of a low molecular weight antigen on melanoma cells by a human antiserum in leukocyte-dependent antibody assays, Br. J. Cancer40: 615.PubMedCrossRefGoogle Scholar
  32. Howe, A. J., Seeger, R. C., Molinaro, G. A., and Ferrone, S., 1981, Analysis of human tumor cells for HLA-DR antigens with monoclonal antibodies, J. Natl. Cancer Inst.66: 827.PubMedGoogle Scholar
  33. Hunt, L. A., 1979, Biosynthesis and maturation of cellular membrane glycoproteins, J. Supramol. Struct.12: 209.PubMedCrossRefGoogle Scholar
  34. Hunt, L. A., Etchison, J. R., and Summers, D. F., 1978, Oligosaccharide chains are trimmed during synthesis of the envelope glycoprotein of vesicular stomatitis virus, Proc. Natl. Acad. Sci. U.S.A.75: 754.PubMedCrossRefGoogle Scholar
  35. Imai, K., and Ferrone, S., 1980, An indirect rosette microassay to characterize human melanoma associated antigens (MAA) recognized by operationally specific xenoantisera, Cancer Res. 40: 2252.PubMedGoogle Scholar
  36. Imai, K., Molinaro, G. A., and Ferrone, S., 1980, Monoclonal antibodies to human melanoma associated anti-gens, Transplant. Proc.12: 380.PubMedGoogle Scholar
  37. Imai, K., Galloway, D. R., and Ferrone, S., 1981a, Serological and immunochemical analysis of the specificity of xenoantiserum 8986 elicited with hybrids between human melanoma cells and murine fibroblasts, Cancer Res. 41: 1028.Google Scholar
  38. Imai, K., Ng, A. K., and Ferrone, S., 1981b, Characterization of monoclonal antibodies to human melanoma-associated antigens, J. Natl. Cancer Inst.66: 489.Google Scholar
  39. Imai, K., Ng, A. K., Glassy, M. C., and Ferrone, S., 1981c, Differential effect of interferon on the expression of tumor-associated antigens and histocompatibility antigens on human melanoma cells: Relationship to susceptibility to immune lysis mediated by monoclonal antibodies, J. Immunol.127: 505.Google Scholar
  40. Imai, K., Pellegrino, M. A., Ng, A. K., and Ferrone, S., 1981d, Role of antigen density in immune lysis of inteferon treated human lymphoid cells: Analysis with monoclonal antibodies to the HLA-A, B antigenic molecular complex and to Ia-like antigens Scand. J. Immunol. 14: 529.CrossRefGoogle Scholar
  41. Imai, K., Ng, A. K., Glassy, M. C., and Ferrone, S., 1981e, ADCC of cultured human melanoma cells: Analysis with monoclonal antibodies to human melanoma associated antigens, Scand. J. Immunol.14: 369.CrossRefGoogle Scholar
  42. Imai, K., Wilson, B. S., Kay, N. E., and Ferrone, S., 1981f, Monoclonal antibodies to human melanoma cells: Comparison of serological results of several laboratories and molecular profile of melanoma-associated antigens, in: Monoclonal Antibodies and T Cell Hybrids( G. J. Hammerling, ed.), Elsevier, New York (in press).Google Scholar
  43. Indiveri, F., Wilson, B. S., Pellegrino, M. A., and Ferrone, S., 1979, Detection of human histocompatibility antigens with an indirect rosette microassay, J. Immunol. Methods29: 101.PubMedCrossRefGoogle Scholar
  44. Irie, R. F., Irie, K., and Morton, D. L., 1976, A membrane antigen common to human cancer and fetal brain cells, Cancer Res. 36: 3510.PubMedGoogle Scholar
  45. Köhler, G., and Milstein, C., 1975, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature (London)256: 495.CrossRefGoogle Scholar
  46. Kurpey, J. Gold, P., and Freedman, S. D., 1978, Physiochemical studies of the carcinoembryonic antigens of the human digestive system, J. Exp. Med. 128:387.Google Scholar
  47. Laemmli, U. K., 1970, Clevage of structural proteins during assembly of the head of bacteriophage T4, Nature (London)222: 680.CrossRefGoogle Scholar
  48. Lee, P.-K., Mari, T., Fujimoto, N., Nakamura, T., Maxuzawa, M., and Kosaki, G., 1979, Relationship of AFP-producing cells in gastric cancer, heptocellular cancer and fetal tissues, in: Carcino-Embryonic Proteins, Vol. 2 ( F. G. Lehmann ed.), pp. 373–381, Elsevier/North-Holland, New York.Google Scholar
  49. Lewis, M. G., and Phillipps, T. M., 1972, Separation of two distinct tumor-associated antibodies in the serum of melanoma patients, J. Natl. Cancer Inst.49: 915.PubMedGoogle Scholar
  50. Martin, W. J., and Imamura, M., 1980, Variable expression of histocompatibility antigens on tumor cells, Cancer Immunol. Immunother.8: 219.CrossRefGoogle Scholar
  51. Mastrangelo, M., Bellet, R. E., and Berd, D., 1979, Immunology and immunotherapy of human cutaneous malignant melanoma, in: Human Malignant Melanoma( W. H. Clark, Jr., M. Mastrangelo, and L. I. Goldman, eds.), pp. 355–416, Grune and Stratton, New York.Google Scholar
  52. McCabe, R. P., Ferrone, S., Pellegrino, M. A., Kern, D. H., Holmes, E. C., and Reisfeld, R. A., 1978, Purification and immunologic evaluation of human melanoma-associated antigens, J. Natl. Cancer Inst.60: 773.PubMedGoogle Scholar
  53. McCabe, R. P., Galloway, D. R., Ferrone, S., and Reisfeld, R. A., 1979a, Human melanoma-associated antigens (MAA): Serologic and structural characterization, in: Current Trends in Tumor Immunology( S. Ferrone, S. Gorini, R. B. Herberman, and R. A. Reisfeld, eds.), pp. 269–286, Garland STPM Press, New York.Google Scholar
  54. McCabe, R. P., Quaranta, V., Frugis, L., Ferrone, S., and Reisfeld, R. A., 19796, A radioimmunometric antibody binding assay for the evaluation of xenoantisera to melanoma associated antigens, J. Natl. Cancer Inst. 62:455.Google Scholar
  55. Mitchell, K. F., Fuhrer, J. P., Steplewski, Z., and Koprowski, H., 1980, Biochemical characterization of human melanoma cell surfaces: Dissection with monoclonal antibodies, Proc. Natl. Acad. Sci. U.S.A.77: 7287.PubMedCrossRefGoogle Scholar
  56. Morton, D. L., Malmgren, R. A., Holmes, E. C., and Ketcham, A. S., 1968, Demonstration of antibodies against human malignant melanoma by immunofluoresence, Surgery64: 233.PubMedGoogle Scholar
  57. Natali, P. G., Cordiali-Fei, P., Cavaliere, R., Di Filippo, F., Quaranta, V., Pellegrino, M. A., and Ferrone, S., 1981, Ia-like antigens on freshly explanted human malignant melanoma, Chn. Immunol. Immuno¢athol.19: 250.CrossRefGoogle Scholar
  58. Parmiani, G., Carbone, G., Invernizzi, G., Pierotti, M. A., Sensi, M. L., Rogers, M. J., and Appella, E., 1979, Alien histocompatibility antigens on tumor cells, Immunogenetics9: 1.CrossRefGoogle Scholar
  59. Pellegrino, M. A., Ferrone, S., and Pellegrino, A., 1972, A simple microabsorption technique for HLA typing, Proc. Soc. Exp. Biol. Med.139: 484.PubMedGoogle Scholar
  60. Pellegrino, M. A., Ferrone, S., Brautbar, C., and Hayflick, L., 1976, Changes in HLA antigen profiles on SV,~ transformed human fibroblasts, Exp. Cell Res.97: 340.PubMedCrossRefGoogle Scholar
  61. Pellegrino, M. A., Ferrone, S., Reisfeld, R. A., Irie, R. F., and Golub, S. H., 1977, Expression of histocom- patibility (HLA) antigens on tumor cells and normal cells from patients with melanoma, Cancer40: 36.PubMedCrossRefGoogle Scholar
  62. Pellegrino, M. A., Weaver, J. F., Nelson-Rees, W. A., and Ferrone, S., 1982, Ia-like and HLA-A B antigens on tumor cells in long term culture, Transplant. Proc.13: 1939.Google Scholar
  63. Pollack, M. S., Heagney, S., and Fogh, J., 1980a, HLA typing of cultured human tumor cell lines: The detection of genetically appropriate HLA-A, B, C and DR alloantigens, Transplant. Proc.12: 134.Google Scholar
  64. Pollack, M. S., Livingston, P. 0., Fogh, J., Carey, T. E., Oettgen, H. F., and Dupont, B., 1980b, Genetically appropriate expression of HLA and DR (IA) alloantigens on human melanoma cell lines, Tissue Antigens15: 249.Google Scholar
  65. Quaranta, V., Walker, L. E., Pellegrino, M. A., and Ferrone, S., 1980, Purification of immunologically functional subsets of human la-like antigens on a monoclonal antibody (Q5/13) immunoadsorbent, J. Immunol.125: 1421.PubMedGoogle Scholar
  66. Quaranta, V., Pellegrino, M. A., and Ferrone, S., 1981a, Serologic and immunochemical characterization of the specificity of four monoclonal antibodies to distinct antigenic determinants expressed on subpopulations of human Ia-like antigens, J. Immunol.126: 548.Google Scholar
  67. Quaranta, V., Walker, L. E., Ruberto, G., Pellegrino, M. A., and Ferrone, S., 1981b, The free and the 02microglobulin-associated heavy chain of HLA-A, B alloantigens share the antigenic determinant recognized by the monoclonal antibody Q1/28, Immunogenetics13: 285.CrossRefGoogle Scholar
  68. Robbins, P. W., Hubbard, S. C., Turco, S. J., and Wirth, D. F., 1977, Proposal for a common oligosaccharide intermediate in the synthesis of membrane glycoproteins, Cell12: 895.CrossRefGoogle Scholar
  69. Rogers, M. J., Appella, E., Pierotti, M. A., Invernizzi, G., and Parmiani, G., 1979, Biochemical characterization of alien H-2 antigens expressed on a methylcholanthrene-induced tumor, Proc. Natl. Acad. Sci. U.S.A.76: 1415.PubMedCrossRefGoogle Scholar
  70. Ruoslahti, E., Pihko, H., and Seppala, M., 1974, Alpha-fetoprotein: Immunochemical purification and chemical properties, expression in normal state and in malignant and non-malignant liver disease, Transplant. Rev.20: 38.PubMedGoogle Scholar
  71. Salisbury, J. G., and Graham, J. M., 1981, Cell surface radioiodination with the sparingly soluble catalyst Iodogen: Differences between dividing and non-dividing populations of rodent thymocytes, Biochem. J.194: 351.PubMedGoogle Scholar
  72. Seibert, E., Sorg, C., Happle, R., and Macher, E., 1977, Membrane-associated antigens of human malignant melanoma. III. Specificity of human sera reacting with cultured melanoma cells, Int. J. Cancer19: 172.PubMedCrossRefGoogle Scholar
  73. Shearman, P. J., Gallatin, W. M., and Longenecker, B. M., 1980, Detection of a cell-surface antigen correlated with organ-specific metastasis, Nature (London)286: 267.CrossRefGoogle Scholar
  74. Shiku, H., Takahasi, T., Oettgen, F., and Old, L. J., 1976, Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens, J. Exp. Med.144: 873.PubMedCrossRefGoogle Scholar
  75. Singer, S. J., 1974, The molecular organization of membranes, Annu. Rev. Biochem.43: 805.CrossRefGoogle Scholar
  76. Stuhlmiller, G. M., and Seigler, H. F., 1975, Characterization of a chimpanzee anti-human melanoma antiserum, Cancer Res. 35: 21–32.Google Scholar
  77. Stuhlmiller, G. M., Boylston, J. A., Seigler, H. F., and Fetter, B. F., 1977, Immunodiagnosis of melanoma using chimpanzee anti-human melanoma antiserum, Am. J. Clin. Pathol.67: 573.PubMedGoogle Scholar
  78. Stuhlmiller, G. M., Green, R. W., and Seigler, H. F., 1978, Solubilization and partial isolation of human melanoma tumor-associated antigens, J. Natl. Cancer Inst.61: 61.PubMedGoogle Scholar
  79. Tabas, I., Schlesinger, S., and Kornfeld, S., 1978, Processing of high mannose oligosaccharides to form complex type oligosaccharides on the newly synthesized polypeptides of the vesicular stomatitis virus G protein and the IgG heavy chain, J. Biol. Chem.253: 716.PubMedGoogle Scholar
  80. Takasugi, M., and Terasaki, P. I., 1972, Detection of HL-A and other cell-surface antigens on cultured cells by a cytotoxic plating inhibition test, J. Natl. Cancer Inst.49: 1229.PubMedGoogle Scholar
  81. Thorsby, E., Bergholtz, B., and Nousiainen, H., 1981, Self-HLA-D-region products restrict human T-lymphocyte activation by antigen, in: Current Trends in Histocompatibility, Vol. 2 (R. A. Reisfeld and S. Ferrone, eds.), Plenum Press, New York (in press).Google Scholar
  82. Truax, H., Barnett, R. N., Hukill, P. B., Campbell, P. C., and Eisenberg, H., 1966, Effect of inaccurate pathological diagnosis on survival statistics for melanoma, Cancer19: 1543.CrossRefGoogle Scholar
  83. Werkmeister, J., Edwards, A., McCarthy, W., and Hersey, P., 1980, Prognostic significance of expression of antigens on melanoma cells, Cancer Immunol. Immunother.9: 233.CrossRefGoogle Scholar
  84. Wilson, B. S., Indiveri, F., Pellegrino, M. A., and Ferrone, S., 1979, DR (Ia-like) antigens on human melanoma cells: Serological detection and immunochemical characterization, J. Exp. Med.149: 658.PubMedCrossRefGoogle Scholar
  85. Wilson, B. S., Indiveri, F., Molinaro, G. A., Quaranta, V., and Ferrone, S., 1980, Characterization of DR antigens on cultured melanoma cells by using monoclonal antibodies, Transplant. Proc.12: 125.PubMedGoogle Scholar
  86. Wilson, B. S., Ng, A. K., Quaranta, V., and Ferrone, S., 1981a, HLA polyclonal and monoclonal xenoantibodies: Production, characterization and application to the study of HLA antigens, in: Current Trends in Histocompatibility, Vol. 2 (R. A. Reisfeld and S. Ferrone, eds.), Plenum Press, New York (in press).Google Scholar
  87. Wilson, B. S., Glassy, M. C., Quaranta, V., Ng, A. K., and Ferrone, S., 1981b, Effect of tunicamycin on the assembly and antigenicity of HLA antigens: Analysis with monoclonal antibodies, Scand. J. Immunol.14: 201.CrossRefGoogle Scholar
  88. Wilson, B. S., Ruberto, G., and Ferrone, S., 1981e, Sulfation and molecular weight of fibronectin shed by human melanoma cells, Biochem. Biophys. Res. Commun.101: 1047.CrossRefGoogle Scholar
  89. Wilson, B. S., Kay, N. E., Imai, K. and Ferrone, S., 1982, Heterogeneity of human melanoma-associated antigens defined by monoclonal antiodies and conventional xenoantigens, Cancer Immunol. Immunother. (in press).Google Scholar
  90. Wilson, N. I., Cochran, A. J., Ross, C. E., Mackie, R. M., Ogg, L. J., and Todd, G., 1979, Immunological aspects of benign melanotic tumors and melanoma in situ, Cancer Immunol. Immunother.6: 27.CrossRefGoogle Scholar
  91. Winchester, R. J., Wang, C. Y., Gibofsky, A., Kunkel, H. G., Lloyd, K. O., and Old, L. J., 1978, Expression of la-like antigens on cultured human malignant melanoma cell lines, Proc. Natl. Acad. Sci. U.S.A.75: 6235.PubMedCrossRefGoogle Scholar
  92. Woodbury, R. G., Brown, J. P., Yeh, M. Y., Hellström, I., and Hellström, K. E., 1980, Identification of a cell surface protein, p97, in human melanoma and certain other neoplasms, Proc. Natl. Acad. Sci. U.S.A.77: 2813.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • Barry S. Wilson
    • 1
  • Kohzoh Imai
    • 1
  • Pier-Giorgio Natali
    • 2
  • Neil E. Kay
    • 1
  • Renato Cavaliere
    • 2
  • Michele A. Pellegrino
    • 1
  • Soldano Ferrone
    • 1
  1. 1.Department of Molecular ImmunologyScripps Clinic and Research FoundationLa JollaUSA
  2. 2.Istituto Regina ElenaRomeItaly

Personalised recommendations